-
-
-
-
-
-
-
Aclaris Therapeutics Announces Key Leadership Transitions
-
-
-
-
-
-
-
Aclaris Therapeutics Reports First Quarter 2021 Financial Results and Provides a Corporate Update
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Aclaris Therapeutics, Carbonite, GTT Communications, and Just Energy and Encourages Investors to Contac
-
-
-
-
-
-
-
Aclaris Therapeutics Reports Third Quarter 2018 Financial Results and Provides Update on Clinical and Commercial Developments
-
-
-
-
-
-
-
Aclaris Therapeutics (ACRS) Names Bryan Reasons as Director and Chairman of the Audit Committee
-
-
-
-
-
-
-
Aclaris Therapeutics (ACRS) Acquires Confluence Life Sciences for $10M Cash, 350K Shares
-
-
-
-
-
-
-
Pre-Open Stock Movers 11/16: (SINO) (DCIX) (TGT) Higher; (PDLI) (FLXN) (LOW) Lower (more...)
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

